Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
19 studies found for:    Open Studies | "Scleroderma, Localized"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Scleroderma, Localized"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Genetic Variants in Linear Localized Scleroderma
Condition: Morphea
Intervention: Other: skin biopsy
2 Recruiting Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Conditions: Scleroderma, Localized;   Morphea;   Frontal Linear Scleroderma en Coup de Sabre;   Scleroderma, Circumscribed;   Scleroderma, Linear
Intervention: Other: Morphea
3 Recruiting The Scleroderma Biorepository and Pathogenesis Study (STOP Scleroderma)
Condition: Scleroderma
Intervention:
4 Recruiting Duke Scleroderma Clinic Patient Registry
Conditions: Scleroderma;   Systemic Sclerosis
Intervention: Other: Registry
5 Recruiting Novel Rehabilitation Strategies to Improve Arm Function in Patients With Scleroderma
Conditions: Scleroderma;   Ssc
Intervention: Other: Occupational therapy treatment
6 Recruiting Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: atorvastatin;   Drug: Placebo
7 Recruiting Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Conditions: SYSTEMIC SCLERODERMA;   ALLOGENEIC MESENCHYMAL STEM CELLS;   ADULT
Intervention: Biological: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
8 Recruiting Scleroderma Registry & Repository at the Hospital for Special Surgery
Condition: Scleroderma
Intervention:
9 Recruiting Scleroderma Registry
Conditions: Systemic Sclerosis;   Scleroderma
Intervention:
10 Recruiting Calcinosis in a Single-Center Scleroderma Population
Conditions: Scleroderma;   Calcinosis
Intervention:
11 Recruiting IL1-TRAP, Rilonacept, in Systemic Sclerosis
Conditions: Scleroderma;   Systemic Sclerosis;   Diffuse Scleroderma;   Diffuse Systemic Sclerosis
Interventions: Drug: Rilonacept;   Drug: Placebo
12 Recruiting Riociguat in Scleroderma Associated Digital Ulcers
Conditions: Scleroderma,;   Digital Ulcers
Interventions: Drug: Riociguat;   Drug: Placebo
13 Recruiting Diltiazem Gel Versus Nitroglycerin Ointment in Healing Process of Scleroderma Digital Ulcers
Condition: Digital Ulcer of Scleroderma
Interventions: Drug: Diltiazem Gel 2%;   Drug: Nitroglycerin Ointment 0.2%;   Drug: Vaseline with Vit E
14 Recruiting Safety & Suitability of Dabigatran to Inhibit Thrombin in Scleroderma
Conditions: Scleroderma;   Interstitial Lung Disease
Intervention: Drug: dabigatran etexilate
15 Recruiting Zibotentan Better Renal Scleroderma Outcome Study
Conditions: Scleroderma;   Scleroderma Renal Crisis;   Chronic Kidney Disease
Intervention: Drug: Zibotentan
16 Recruiting Gastroesophageal Reflux Treatment in Scleroderma
Conditions: Gastroesophageal Reflux Disease;   Systemic Sclerosis;   Scleroderma
Interventions: Drug: Alginic acid;   Drug: placebo (for domperidone);   Drug: Domperidone;   Drug: placebo (of alginic acid)
17 Recruiting Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic;   Scleroderma, Limited;   Sclerosis, Progressive Systemic;   Skin Diseases;   Connective Tissue Diseases;   Pathologic Processes;   Autoimmune Diseases
Interventions: Drug: Oral Ifetroban;   Drug: Oral Placebo
18 Recruiting Obstructive Sleep Apnea in Scleroderma and Pulmonary Involvement
Conditions: Scleroderma, Systemic;   Sleep Apnea, Obstructive;   Pulmonary Disease
Intervention: Other: No intervention
19 Recruiting Microvascular and Fibrosis Imaging Study
Conditions: Autoimmune Diseases;   Sickle Cell Disease;   Chronic Graft Versus Host Disease
Interventions: Other: Acoustic Radiation Force Impulse (ARFI);   Other: Laser Doppler Flowmetry (LDF);   Other: Laser Doppler Perfusion Imaging (LDI);   Other: Optical Coherence Tomography (OCT);   Other: Orthogonal Polarization Spectral Imaging (OPSI);   Other: Nail fold video capillaroscopy (NVC)

Study has passed its completion date and status has not been verified in more than two years.